Literature DB >> 23175330

[Potential pathogens in multiple sclerosis (MS)].

Mariola Zawada1.   

Abstract

Multiple sclerosis is a neuroimmunological disease in which etiologic agents have not been identified yet. The etiology of MS is complex in its nature and may involve many different agents acting simultaneously or in a cascade manner leading to the development of the disease. The causes of MS development were sought among the factors associated with HLA and TCR genes and human endogenous retroviruses (HERV). Environmental factors such as bacterial, fungal and viral infections as well as potential participation of vitamin D in the pathogenesis of the disease have also been examined. The current state of knowledge concerning potential factors participating in the etiopathogenesis of multiple sclerosis has been reviewed in this paper.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23175330     DOI: 10.5604/17322693.1015041

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  3 in total

1.  Frequency of human endogenous retroviral sequences (HERV) K113 and K115 in the Polish population, and their effect on HIV infection.

Authors:  Katarzyna Zwolińska; Brygida Knysz; Jacek Gąsiorowski; Monika Pazgan-Simon; Andrzej Gładysz; Maciej Sobczyński; Egbert Piasecki
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

2.  Cerebrospinal Fluid in a Small Cohort of Patients with Multiple Sclerosis Was Generally Free of Microbial DNA.

Authors:  Juan Jovel; Sandra O'keefe; Jordan Patterson; Michael Bording-Jorgensen; Weiwei Wang; Andrew L Mason; Kenneth G Warren; Gane Ka-Shu Wong
Journal:  Front Cell Infect Microbiol       Date:  2017-01-06       Impact factor: 5.293

3.  Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients - preliminary study.

Authors:  Julia Rudnicka; Michał Czerwiec; Ewelina Grywalska; Dorota Siwicka-Gieroba; Monika Walankiewicz; Agnieszka Grafka; Michał Zgurski; Agata Surdacka; Halina Bartosik-Psujek; Jacek Roliński
Journal:  Cent Eur J Immunol       Date:  2015-10-15       Impact factor: 2.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.